Suncoast Equity Management’s MIRA Pharmaceuticals MIRA Stock Holding History

Suncoast Equity Management’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90,645	Closed	-$97K	–	84
2026 Q1	$97K	Sell	90,645 -12,644	-12%	-$15.9K	0.01%	90
2025 Q4	$156K	Hold	103,289	–	–	0.02%	85
2025 Q3	$140K	Hold	103,289	–	–	0.01%	87
2025 Q2	$125K	Hold	103,289	–	–	0.01%	82
2025 Q1	$101K	Buy	103,289 +80,645	+356%	+$91.9K	0.01%	79
2024 Q4	$25.8K	Sell	22,644 -67,356	-75%	-$88K	﹤0.01%	76
2024 Q3	$117K	Buy	90,000 +50,000	+125%	+$79.7K	0.01%	70
2024 Q2	$25.5K	Hold	40,000	–	–	﹤0.01%	71
2024 Q1	$44K	Buy	+40,000	New	+$43.4K	0.01%	71

Other funds holding MIRA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CSI

Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Suncoast Equity Management's MIRA Position: Q2 2026 in Review

Suncoast Equity Management sold out of MIRA Pharmaceuticals (MIRA) in Q2 2026, closing a stake of 90,645 shares — an estimated $97K sold.

Suncoast Equity Management first reported a position in MIRA in Q1 2024 and held it in 9 quarters. The position peaked at $156K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

Suncoast Equity Management reported no remaining MIRA Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Suncoast Equity Management sold 90,645 MIRA Pharmaceuticals shares in Q2 2026, an estimated $97K.
Suncoast Equity Management first reported a position in MIRA Pharmaceuticals in Q1 2024 and held it in 9 quarters.
Suncoast Equity Management's MIRA Pharmaceuticals position peaked at $156K in Q4 2025.
26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Suncoast Equity Management's 13F filing for Q2 2026, filed 4 Aug 2026.